[ad_1]
This article is over a month old and may contain outdated advice from authorities regarding coronary heart disease.
Stay up to date on the NRK overview or on the FHI website.
The pharmaceutical companies Pfizer and BioNTech have developed the vaccine. It should be stored at minus 78 degrees during transportation and storage so that it is not damaged. The vaccine should be given in two doses at three week intervals.
Superfryses
– This vaccine must be kept frozen in super freezers. It should be thawed and used immediately after thawing. This is what the director of the Norwegian Medicines Agency, Steinar Madsen, says.
The vaccine is destroyed at room temperature.
The Norwegian Medicines Agency must approve storage, transport and the stage from thawing to vaccination.
– General plans for this should be ready on December 1, says Madsen.
The NIPH has plans to distribute a vaccine throughout the country.
Photo: Thomson Reuters
It can be challenging to distribute the vaccine across the country due to the temperature.
The National Institute of Public Health is responsible for making plans for how to distribute the vaccine safely.
– We have systems for that, says FHI’s director of infection control, Geir Bukholm.
The pharmaceutical company Pfizer, which developed the vaccine, produces containers for transporting and storing the vaccine. Pfizer is expected to help ensure that the vaccine is not destroyed.
– We must see the final contract between Pfizer and the EU, but plans have been made for this, says Bukholm.
Good news
Health Minister Bent Høie confirmed on Monday that the Pfizer vaccine could also be available in Norway.
– All the good news about vaccines is good for us too. This is one of the vaccines in the package the EU is working on and of which Norway is also part.
– Then we have to verify the information and then it will follow the usual approval procedures, says Høie.
Pfizer and BioNTech have an agreement with the EU to deliver the vaccine to countries in the EU area. Norway will therefore also have access to the vaccine, which will be sold to Norway through the EU country Sweden.
Several research groups are working hard to develop vaccines against covid-19.
Photo: bond Science Communication
It looks like it will be the first vaccine in Norway.
